Diagnoisis of neural crest tumors by reversed-phase high-performance liquid chromatographic determination of urinary catecholamine metabolites
- 30 December 1979
- journal article
- Published by Elsevier BV in Journal of Chromatography A
- Vol. 186, 733-748
- https://doi.org/10.1016/s0021-9673(00)95292-0
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Biochemical screening for neural crest tumorsin childhoodJournal of Pediatric Surgery, 1975
- Catecholamines and Indoleamines in Patients With Duchenne Muscular DystrophyArchives of Neurology, 1972
- The biochemical techniques for detecting and establishing the presence of a pheochromocytoma: A review of ten years' experienceThe American Journal of Cardiology, 1970
- Diagnosis of neuroblastoma by qualitative and quantitative determination of catecholamine metabolites in urineCancer, 1970
- Pheochromocytoma: Current Concepts of Diagnosis and TreatmentAnnals of Internal Medicine, 1966
- A quantitative assay for vanillylmandelic acid (VMA) by gas-liquid chromatographyAnalytical Biochemistry, 1965
- Determination of 3-methoxy-4-hydroxymandelic acid in urineClinica Chimica Acta; International Journal of Clinical Chemistry, 1962
- Determination of urinary 3-methoxy-4-hydroxymandelic acid in manClinica Chimica Acta; International Journal of Clinical Chemistry, 1961
- THE DIAGNOSIS OF PHEOCHROMOCYTOMA BY DETERMINATION OF URINARY 3-METHOXY,4-HYDROXYMANDELIC ACID*†JCI Insight, 1960
- 3-Methoxy-4-hydroxy-D-mandelic acid, a urinary metabolite of norepinephrineBiochimica et Biophysica Acta, 1957